Essex Bio-Technology Limited (HKG:1061)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.000
-0.040 (-1.32%)
Jun 1, 2026, 3:59 PM HKT

Revenue by Segment

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Healthcare and Partner Services
82.87M18.42M11.54M--
Healthcare and Partner Services Growth
349.80%59.68%---
Surgical
895.90M879.90M970.40M764.15M964.39M
Surgical Growth
1.82%-9.33%26.99%-20.76%72.56%
Ophthalmology
835.03M771.49M755.03M553.56M673.27M
Ophthalmology Growth
8.24%2.18%36.40%-17.78%60.60%
Total
1.81B1.67B1.74B1.32B1.64B
Total Growth
8.62%-3.87%31.82%-19.54%67.43%

Revenue by Geography

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
People's Republic of China (The PRC)
1.80B1.66B1.73B1.32B1.64B
People's Republic of China (The PRC) Growth
8.47%-4.02%31.43%-19.54%67.43%
Overseas
10.70M7.52M5.10M--
Overseas Growth
42.28%47.48%---
Total
1.81B1.67B1.74B1.32B1.64B
Total Growth
8.62%-3.87%31.82%-19.54%67.43%
Source: S&P Global Market Intelligence.